NCT05051098

A Non-interventional Registry for Patients with Hepatitis B Virus Infection

The European HBV Registry: a Joint Initiative of TherVacB and DZIF

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 3,000 (estimated)
• Sponsor: Hannover Medical School · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

In order to tackle the unmet needs in chronic HBV infection, a consortium of clinical partners has gathered to establish a registry for patients with hepatitis B mono- and co-infections. The partners will build up a European-wide registry to be able to stratify patients for upcoming clinical trials. Extensive analyses of virus and host-specific parameters are to be carried out from these patients. The knowledge gained thereby should contribute to a better understanding of the HBV control and enable patient stratification with regard to immunomodulatory therapies. Furthermore, hepatitis B patients are to be identified who are willing to participate in future studies to investigate immunotherapies to cure HBV infections (e.g. therapeutic vaccines).

Conditions

• Hepatitis B Virus Infection

Interventions

Type	Name	Description
OTHER	No intervention	No intervention

Timeline

• Start date: 2021-05-06
• Primary completion: 2025-12-01
• Completion: 2025-12-01
• First posted: 2021-09-21
• Last updated: 2025-03-13

Locations

1 site across 1 country: Germany